Abstract
The selection of 100mcg or 150mcg corifollitropin alfa in IVF/ICSI cycles depends on the body weight of the patients with good prognosis. A higher percentage of excessive ovarian response and consequent cancellation is found in corifollitropin alfa compared to daily FSH with GnRH antagonist protocols. However, the excessive ovarian response in corifollitropin alfa protocol did not jeopardize the ongoing pregnancy rate and might be predicted by serum anti-Mullerian hormone levels. This analysis tried to prove the concept that 100mcg corifollitropin alfa is adequate for all patients with a high AMH level (>3.5 ng/ml).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
